• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Paving the Path for Increased Technological Innovation, Strategic Decision Making and Regulatory Acceptance of Modeling and Simulation Approaches.

作者信息

Fang Lanyan, Tsakalozou Eleftheria, Polli James E

机构信息

Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.

Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD, USA.

出版信息

Pharm Res. 2025 May;42(5):727-729. doi: 10.1007/s11095-025-03868-6.

DOI:10.1007/s11095-025-03868-6
PMID:40437346
Abstract
摘要

相似文献

1
Paving the Path for Increased Technological Innovation, Strategic Decision Making and Regulatory Acceptance of Modeling and Simulation Approaches.为建模与仿真方法在技术创新、战略决策制定及监管认可方面的提升铺平道路。
Pharm Res. 2025 May;42(5):727-729. doi: 10.1007/s11095-025-03868-6.
2
The Impact of Proactive Personality on Career Decision-Making Self-Efficacy: The Role of AI Acceptance and Innovation Skills.积极型人格对职业决策自我效能的影响：人工智能接受度与创新技能的作用。
Behav Sci (Basel). 2025 Apr 16;15(4):538. doi: 10.3390/bs15040538.
3
Critical success factors for successful technology innovation development in sustainable energy enterprises.可持续能源企业成功进行技术创新发展的关键成功因素。
Sci Rep. 2025 Apr 23;15(1):14138. doi: 10.1038/s41598-025-98725-2.
4
Measuring the Enterprise Green Innovation Strategy Decision-Making Quality: A Moderating-Mediating Model.衡量企业绿色创新战略决策质量：一个调节-中介模型。
Front Psychol. 2022 Jun 13;13:915624. doi: 10.3389/fpsyg.2022.915624. eCollection 2022.
5
The dynamic relationship among green logistics, technological innovation and green economy: Evidence from China.绿色物流、技术创新与绿色经济之间的动态关系：来自中国的证据。
Heliyon. 2024 Feb 15;10(4):e26534. doi: 10.1016/j.heliyon.2024.e26534. eCollection 2024 Feb 29.
6
Advancing in Silico Clinical Trials for Regulatory Adoption and Innovation.推进用于监管采用和创新的计算机模拟临床试验。
IEEE J Biomed Health Inform. 2025 Apr;29(4):2654-2668. doi: 10.1109/JBHI.2024.3486538. Epub 2025 Apr 4.
7
The Path to Innovation: The Antecedent Perspective of Intellectual Capital and Organizational Character.创新之路：智力资本与组织特征的先行视角
Front Psychol. 2018 Dec 4;9:2445. doi: 10.3389/fpsyg.2018.02445. eCollection 2018.
8
Dynamic strategy for low-carbon supply chain considering retailers competition and technological innovation.考虑零售商竞争与技术创新的低碳供应链动态策略
Heliyon. 2024 Mar 6;10(6):e27474. doi: 10.1016/j.heliyon.2024.e27474. eCollection 2024 Mar 30.
9
Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop.医疗产品开发与评估的建模和仿真：2013年美国食品药品监督管理局-临床路径-国际系统与程序标准化组织研讨会要点
J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):545-52. doi: 10.1007/s10928-014-9390-0. Epub 2014 Oct 7.
10
Unlocking the carbon emission efficiency improvement path of technological innovation: a perspective on industrial restructuring and R&D element flows.解锁技术创新的碳减排效率提升路径：产业结构调整与研发要素流动视角
Environ Sci Pollut Res Int. 2024 Mar;31(14):21189-21207. doi: 10.1007/s11356-024-32510-y. Epub 2024 Feb 22.

本文引用的文献

1
Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future.基于 PBPK 模型的剂量优化：现状与未来。
Clin Pharmacol Ther. 2024 Sep;116(3):563-576. doi: 10.1002/cpt.3289. Epub 2024 Apr 30.
2
Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report.基于生理学的生物药剂学建模 (PBBM)：药品质量、监管和行业视角的最佳实践：2023 年研讨会总结报告。
Mol Pharm. 2024 May 6;21(5):2065-2080. doi: 10.1021/acs.molpharmaceut.4c00202. Epub 2024 Apr 10.
3
Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program.
行业考虑因素-为 FDA 模型指导药物开发 (MIDD) 配对会议计划做准备。
Clin Pharmacol Ther. 2024 Aug;116(2):282-288. doi: 10.1002/cpt.3245. Epub 2024 Mar 22.
4
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA.模型主文件在与 FDA 共享、接受和沟通方面的作用。
AAPS J. 2024 Feb 27;26(2):28. doi: 10.1208/s12248-024-00897-8.
5
Using Mechanistic Modeling Approaches to Support Bioequivalence Assessments for Oral Products.利用机制建模方法支持口服产品的生物等效性评估。
AAPS J. 2024 Jan 24;26(1):19. doi: 10.1208/s12248-024-00886-x.
6
Use of the Same Model or Modeling Strategy Across Multiple Submissions: Focus on Complex Drug Products.在多个提交中使用相同的模型或建模策略：关注复杂药物产品。
AAPS J. 2024 Jan 4;26(1):12. doi: 10.1208/s12248-023-00879-2.
7
Role of Physiologically Based Biopharmaceutics Modeling (PBBM) in Fed Bioequivalence Study Waivers: Regulatory Outlook, Case Studies and Future Perspectives.生理相关的生物药剂学建模（PBBM）在进食生物等效性研究豁免中的作用：监管展望、案例研究和未来展望。
J Pharm Sci. 2024 Feb;113(2):345-358. doi: 10.1016/j.xphs.2023.11.030. Epub 2023 Dec 1.
8
Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case Study.将生物相关儿科溶出度方法学整合到 PBPK 建模中，以预测儿科人群中仿制药的体内性能和生物等效性：卡马西平案例研究。
AAPS J. 2023 Jun 29;25(4):67. doi: 10.1208/s12248-023-00826-1.
9
Leveraging Prior Healthy Participant Pharmacokinetic Data to Evaluate the Impact of Renal and Hepatic Impairment on Ritlecitinib Pharmacokinetics.利用既往健康参与者的药代动力学数据评估肾功能和肝功能损害对瑞特替尼药代动力学的影响。
AAPS J. 2023 Mar 28;25(3):32. doi: 10.1208/s12248-023-00792-8.
10
Increasing impact of quantitative methods and modeling in establishment of bioequivalence and characterization of drug delivery.定量方法和建模在生物等效性确立及药物递送特性表征中的影响日益增大。
CPT Pharmacometrics Syst Pharmacol. 2023 May;12(5):552-555. doi: 10.1002/psp4.12930. Epub 2023 Feb 9.